We use press releases to update external stakeholders on our progress. We want to make sure you have all the information you need to provide comprehensive feedback on our reports.
Subscribers can expect to receive press releases at the following milestones: Topic Announcement, Draft Evidence Report, Revised Evidence Report, and Final Evidence Report.
You can also find the week’s press releases in our newsletter.
For any questions, please contact mediainquiries@icer.org.
Sign up for our Press Releases and Newsletter!
Subscribe now!
Featured Press Releases
ICER Identifies Most Significant 2020 US Drug-Price Hikes Not Supported by New Clinical Evidence*
Out of 10 identified drugs that had substantial 2020 price increases net of rebates on top of already high current spending, seven were not supported by new clinical evidence; the net price increases on these seven drugs cost Americans an additional $1.67 billion in annual drug spend, of which nearly $1.4 billion was due to […]
11/16/2021ICER Publishes Final Evidence Report and Policy Recommendations on Aducanumab for Alzheimer’s Disease
Independent appraisal committee unanimously determined the evidence is not adequate to demonstrate that aducanumab provides a net health benefit.
08/05/2021ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports, Helping Payers, the Life Science Industry, and Health Care Policy Makers Move From Insight to Action
ICER formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices.
11/30/2020